Skip to main content
Delfa

Lead sponsor

Ohio State University

3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.

3

Trials led

2

Ongoing

23,280,660

Total enrollment

6

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1
Not applicable
2

Trials by status

Recruiting
1
Active, not recruiting
1
Completed
1

Trials led

DASH-CKMH-not applicableActive, not recruiting23,280,000
Improving Beta Cell Function in Mexican American Women With PrediabetesBMI 30-42Ph 4Completed360
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists-not applicableRecruiting300